Home / Medical Equipments / Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada

Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada

Published: Feb 2015 | No Of Pages: 53 | Published By: Renub Research

Product Synopsis

The improvement in technology, surgical techniques and immunosuppressive drugs, Kidney transplantation has became the preferred treatment for chronic kidney disease for many people. A transplant may offer the best chance of returning to a more normal life. Kidney transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end stage kidney disease (ESRD).

North America is one of the biggest kidney transplant market in the world. The overall number of Kidney Transplant done in North America (United States, Mexico and Canada) was more than 20 Thousand in 2014. United States is the leader in kidney transplant market in North America. Canada has the least number of kidney transplant done in comparison to United States and Mexico. Despite its high medical cost today United States Kidney Transplant Market is a Billion US$ industry.

All the 3 Countries studied in the report are as follows

United States
Canada
Mexico

All the 6 Kidney Transplant Immunosuppressant) drugs studied in the report are as follows

CellCept (MycophenolateMofetil)
Prograf (Tacrolimus)
Rapamune (Sirolimus)
Myfortic (Mycophenolic Acid)
Neoral / Sandimmune (Cyclosporine)
Zortress / Certican (Everolimus)

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.

1. Executive Summary

2. North America (United States, Mexico & Canada) – Number of Kidney Transplant & Forecast

3. North America (United States, Mexico & Canada) – Kidney Transplant Market & Forecast

4. North America (United States, Mexico & Canada) – Number of Kidney Transplant, Market & Drugs Market Share & Forecast
4.1 North America (United States, Mexico & Canada) – Number of Kidney Transplant Share & Forecast
4.2 North America (United States, Mexico & Canada) – Kidney Transplant Market Share & Forecast
4.3 Number of Kidney Transplant Centers in United States, Canada & Mexico

5. United States
5.1 United States – Number of Kidney Transplant & Forecast
5.2 United States – Kidney Transplant Market & Forecast

6. Mexico
6.1 Mexico – Number of Kidney Transplant & Forecast
6.2 Mexico – Kidney Transplant Market & Forecast

7. Canada
7.1 Canada – Number of Kidney Transplant & Forecast
7.2 Canada – Kidney Transplant Market & Forecast

8. Kidney Transplantation (Immunosuppressant) Drug Sales Analysis
8.1 CellCept (MycophenolateMofetil) Drugs Sales & Forecast
8.2 Prograf (Tacrolimus) Drug Sales & Forecast
8.3 Rapamune (Sirolimus) Drug Sales & Forecast
8.4 Myfortic (Mycophenolic Acid) Drug Sales & Forecast
8.5 Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
8.6 Zortress / Certican (Everolimus) Drug Sales & Forecast

9. Growth Drivers in the Kidney Transplant Market
9.1 Frequency of Living Related Kidney Donation Has Increased
9.2 Patients Who Have Kidney Transplants Usually Live Longer Than Patients Receiving Dialysis

10. Challenges in the Kidney Transplant Market
10.1 Kidney Transplant Waitlist is Long

Table 4 1: United States, Mexico & Canada - Kidney Transplant Centers (Number), 2014 

Figure 2 1: North America (United States, Mexico & Canada) – Number of Kidney Transplant (Number), 2006 – 2014
Figure 2 2: North America (United States, Mexico & Canada) – Forecast for Number of Kidney Transplant (Number), 2015 – 2020
Figure 3 1: North America (United States, Mexico & Canada) – Kidney Transplant Market (Million US$), 2006 – 2014
Figure 3 2: North America (United States, Mexico & Canada) – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 4 1: North America (United States, Mexico & Canada) – Number of Kidney Transplant Share (Percent), 2006 – 2014
Figure 4 2: North America (United States, Mexico & Canada) – Forecast for Number of Kidney Transplant Share (Percent), 2015 – 2020
Figure 4 3: North America (United States, Mexico & Canada) – Kidney Transplant Market Share (Percent), 2006 – 2014
Figure 4 4: North America (United States, Mexico & Canada) – Kidney Transplant Market Share (Percent), 2015 – 2020
Figure 5 1: United States – Number of Kidney Transplant (Number), 2004 – 2014
Figure 5 2: United States – Forecast for Number of Kidney Transplant (Number), 2015 – 2020
Figure 5 3: United States – Kidney Transplant Market (Million US$), 2004 – 2014
Figure 5 4: United States – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 6 1: Mexico – Number of Kidney Transplant (Number), 2006 – 2014
Figure 6 2: Mexico – Forecast for number of Kidney Transplant (Number), 2015 – 2020
Figure 6 3: Mexico – Kidney Transplant Market (Million US$), 2006 – 2014
Figure 6 4: Mexico – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 7 1: Canada – Number of Kidney Transplant (Number), 2004 – 2014
Figure 7 2: Canada – Forecast for number of Kidney Transplant (Number), 2015 – 2020
Figure 7 3: Canada – Kidney Transplant Market (Million US$), 2004 – 2014
Figure 7 4: Canada – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 9 1: Worldwide – CellCept Drug Sales (Million US$), 2005 – 2014
Figure 9 2: Worldwide – Forecast for CellCept Drug Sales (Million US$), 2015 – 2020
Figure 9 3: Worldwide – Prograf Drug Sales (Million US$), 2004 – 2014
Figure 9 4: Worldwide – Forecast for Prograf Drug Sales (Million US$), 2015 – 2020
Figure 9 5: Worldwide – Rapamune Drug Sales (Million US$), 2009 – 2014
Figure 9 6: Worldwide – Forecast for Rapamune Drug Sales (Million US$), 2015 – 2020
Figure 9 7: Worldwide – Myfortic Drug Sales (Million US$), 2008 – 2014
Figure 9 8: Worldwide – Forecast for Myfortic Drug Sales (Million US$), 2015 – 2020
Figure 9 9: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2007 – 2014
Figure 9 10: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2015 – 2020
Figure 9 11: Worldwide – Zortress/Certican Drug Sales (Million US$), 2008 – 2014
Figure 9 12: Worldwide – Forecast for Zortress / Certican Drug Sales (Million US$), 2015 – 2020
Figure 10 1: United States – Number of Kidney Living Donor (Number), 2000 – 2013
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +